At Dynamill Research, we are proud to collaborate with DM Clinical as our preferred Site Management Organization (SMO) partner. This relationship brings together Dynamill’s diagnostics-focused CRO expertise and DM Clinical’s robust national site infrastructure to deliver integrated, end-to-end clinical trial execution. By combining our tailored trial designs and regulatory insight with DM Clinical’s proven site-level performance, we accelerate patient recruitment, enhance data quality, and ensure operational excellence from protocol to closeout. Together, we offer diagnostics companies a seamless and scalable solution to bring innovative tests to market faster.